USEFUL IMMUNOTHERAPEUTIC AGENT FOR THE COMBINED TREATMENT OF TUBERCULOSIS IN ASSOCIATION WITH OTHER DRUGS

• 1. 用于与其它药物一起联合治疗结核的免疫治疗剂 [P] . 中国专利： CN100490894C . 2009.05.27
• 2. 用于与其它药物一起联合治疗结核的免疫治疗剂 [P] . 中国专利： CN1874785A . 2006-12-06
• 3. USEFUL IMMUNOTHERAPEUTIC AGENT FOR THE COMBINED TREATMENT OF TUBERCULOSIS IN ASSOCIATION WITH OTHER DRUGS [P] . CA2543659C . 2012-04-17

  机译： 结合其他药物联合治疗肺结核的有用的免疫治疗剂

• 4. Immunotherapeutic agent for the combined treatment of tuberculosis in association with other drugs [P] . 美国专利： US8246944B2 . 2012-08-21

  机译： 结合其他药物联合治疗结核病的免疫治疗剂

• 5. Useful immunotherapeutic agent for the combined treatment of tuberculosis in association with other drugs, method of obtention and pharmaceutical compositions [P] . AU2004285305B2 . 2009-11-12

  机译： 用于与其他药物联合治疗结核的有用的免疫治疗剂，治疗方法和药物组合物

• 1. Synergistic Effects of 18β-glycyrrhetinic Acid Combined with Antituberculosis Drugs against Mycobacterium tuberculosis [J] . Jia Fang, Xing Liqun 动物与饲料科学：英文版 . 2015,第001期
• 2. Association of Genetic Polymorphism of GSTM1 and GSTT1 with the Susceptibility to Antituberculosis Drug-induced Hepatotoxicity in Chinese Population [J] . Gang Xiao 医学科学进展杂志(英文) . 2018,第003期
• 3. Association of Drug Susceptibility Testing Results for First- and Second-line Drugs With Treatment Outcomes in Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Reply [J] . Bastos Mayara L., Menzies Dick Clinical infectious diseases . 2015,第8期
• 4. Association of Drug Susceptibility Testing Results for First- and Second-line Drugs With Treatment Outcomes in Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis [J] . Wang Hong-min, Zhang Xiao-Hong Clinical infectious diseases . 2015,第8期
• 5. Association of Drug Susceptibility Testing Results for First- and Second-line Drugs With Treatment Outcomes in Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Reply [J] . Bastos Mayara L., Menzies Dick Clinical infectious diseases . 2015,第8期
• 6. Effect of Solvent and Drug Impregnation Techniques on Total Drug Content in Rifampicin Impregnated Hydroxyapatite for Localized Bone Tuberculosis Treatment [C] . Waraporn Suvannapruk, Jintamai Suwanprateeb International Conference on Traditional and Advanced Ceramics . 2016
• 7. Improving the treatment of experimental tuberculosis with combined rifapentine- and moxifloxacin-containing drug regimens. [D] . Rosenthal, Ian M. 2007
• 8. COMBINED DRUG TREATMENT OF TUBERCULOSIS. III. CLINICAL APPLICATION OF THE PRINCIPLES OF APPROPRIATE AND ADEQUATE CHEMOTHERAPY TO THE TREATMENT OF PULMONARY TUBERCULOSIS [O] . William F. Russell Jr., Irving Kass, Angeline D. Heaton, 1959
• 9. THE EFFECT OF DIFFERENT TB DRUGS AND ANTIMICROBIAL AGENTS ON THE EFFICIENCY OF TREATMENT OF TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE [O] . I. A. Vasilyeva, A. G. Samoylova, O. V. Lovacheva, 2017

• 1. Late Commencement of Anti-Tuberculosis Drugs in Three Directly Observed Treatment Short Course Centres in Benue State Nigeria: A Neglected Correlate of Tuberculosis Management [J] . Onyemocho Audu ,Shember AgelaIgbabul ,Joseph Anejo-Okopi . 结核病研究（英文） . 2017,第2期
• 2. Association between Weight Change during Treatment and Treatment Outcome in Patients with Smear Positive Pulmonary Tuberculosis [J] . Mohammad Khajedaluee ,Maliheh Dadgarmoghaddam ,Davoud Attaran . 预防医学期刊（英文） . 2014,第6期
• 3. Prevalence and Risk Factors of Adverse Drug Reactions Associated Multidrug Resistant Tuberculosis Treatments in Selected Treatment Centers in Addis Ababa Ethiopia [J] . Haregewoin Bezu ,Daniel Seifu ,Getnet Yimer . 结核病研究（英文） . 2014,第3期
• 4. 一等奖:化学药物联合免疫调节剂治疗矽肺结核疗效观察 [C] . 朱启上 ,彭莉君 ,伏代刚 . 中华医学会结核病学分会2004年学术会议 . 2004
• 5. 中西药物结合对母猪奶质及哺乳仔猪免疫力和生产性能的影响 [A] . 张迪 . 2019